Business Wire

NC-LENOVO

8.9.2021 06:02:11 CEST | Business Wire | Press release

Share
Lenovo Launches Global Everything-as-a-Service Strategy

Today, at its annual Tech World event, Lenovo announced an evolution in its consumption-based business model, introducing Lenovo TruScale , a new portfolio-spanning everything-as-a-service offering. This announcement is part of Lenovo’s continuing transformation for the next reality – a new era where consumers and business leaders need new solutions and technologies to face unprecedented change in business, education, living and beyond.

Expanding its TruScale brand beyond infrastructure services, Lenovo is bringing all of its as-a-service offerings under one umbrella to provide a truly global solution that makes everything from the pocket to the cloud available via a single contract framework. Lenovo TruScale embodies the company’s vision and transformation for the next reality – meeting the growing global demand for smarter technology amid a new era of hybrid working and learning.

“Digital transformation is accelerating faster than ever, and companies are struggling to keep pace with the speed of innovation. We hear from CIOs every day that their organizations’ technology needs are evolving every 12-18 months,” said Ken Wong, president of Solutions & Services Group. “With Lenovo TruScale, customers can expect one solution, one provider, one contract framework, and a single point of accountability for everything-as-a-service.”

Lenovo TruScale offers businesses of all sizes an everything-as-a-service platform with the flexibility they need to stay competitive with a scalable, cloud-like consumption model and predictable payment options for hardware and service inclusions. This transition to a fully integrated as-a-service strategy brings to life the company’s “One Lenovo” vision – addressing common business challenges and providing IT leaders with the performance and flexibility to pay-as-you-grow. With Lenovo TruScale, IT leaders’ infrastructure solutions are fully managed, giving customers the advantages of an on-premise cloud environment along with the peace of mind around data management in a hybrid environment.

Research shows the as-a-service market is growing at four times the overall IT services total addressable market. In three years, as-a-service models will represent 12% of enterprise x86 server spend and over 50% of new enterprise storage spend, growing at 40% CAGR and around 17% of commercial PC spend, up from 1% two years ago and growing at 50% CAGR.1

As the world shifts to a flexible “work, learn and connect-from-anywhere” model, organizations that embrace smarter technology designed for a hybrid reality will benefit from this transition. This requires flexibility in devices and work platforms, on-demand support when and where needed, and customizable solutions across the organization, benefits that many will recognize from Lenovo’s existing Device-as-a-Service solution. Now moving under the new TruScale umbrella, Lenovo DaaS will continue to help customers move to a Modern IT environment by combining the best end-to-end technology from across Lenovo with lifecycle services and support and convenient financing to deliver lower total cost of ownership.

Lenovo is building a new way to deliver as-a-service to the market and offer organizations ultimate flexibility in how they leverage their IT infrastructure, services and software. By forming strategic alliances with other market leaders, customers can get the public cloud experience with the security and control of an on-premises solution. As part of this new platform, Lenovo has joined with leading infrastructure partners Deloitte, VMWare and Intel, and DaaS security partners Absolute Software and SentinelOne to provide organizations with various dynamic offerings such as hybrid cloud solutions for Edge to Cloud environments, best-in-class managed security solutions and access to the most current storage infrastructure innovation, for the life of their data, with the ability to scale storage capacity on demand.

“Lenovo’s as-a-service approach helps meet the market's demand for responsive, reliable hybrid cloud operations. Put simply our organizations are helping companies grow their enterprises and mitigate risks to create more value and serve society better,” said Punit Renjen, CEO of Deloitte Global.

Learn more about TruScale’s latest offerings at Lenovo’s annual global innovation event, Tech World .

1 Gartner, IDC, Lenovo Market Intelligence

About Lenovo

Lenovo (HKSE: 992) (ADR: LNVGY) is a US$60 billion revenue Fortune Global 500 company serving customers in 180 markets around the world. Focused on a bold vision to deliver smarter technology for all, we are developing world-changing technologies that power (through devices and infrastructure) and empower (through solutions, services and software) millions of customers every day and together create a more inclusive, trustworthy and sustainable digital society for everyone, everywhere. To find out more visit https://www.lenovo.com and read about the latest news via our StoryHub .

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release

- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release

New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release

Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea

Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press release

Phase Ia BreAK CRC-001 at ESMO 2026: 43% of patients, all initially unresectable, became eligible for surgery Poster 1023P – Developmental Therapeutics Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by u

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye